110 related articles for article (PubMed ID: 16312828)
1. Second and third line chemotherapy in advanced breast cancer.
Alexopoulos A; Rigatos G; Stavrinidis E; Stavrakakis J; Scartsilas C; Papacharalambous A
J Chemother; 1989 Jul; 1(4 Suppl):1189-90. PubMed ID: 16312828
[No Abstract] [Full Text] [Related]
2. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
[TBL] [Abstract][Full Text] [Related]
3. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
Ardavanis A; Tryfonopoulos D; Orphanos G; Ioannidis G; Karamouzis M; Rigatos G
Anticancer Res; 2005; 25(6C):4493-8. PubMed ID: 16334132
[TBL] [Abstract][Full Text] [Related]
4. [A case of advanced breast cancer leading to DIC after chemotherapy].
Ishizuka S; Morikawa T; Yoshida K; Nobuhisa T; Endo Y; Watanabe T; Matsumoto Y; Doi Y; Yamada T; Kai K; Nakashima A; Nagahiro I; Sato S; Nakashima A; Nabeyama A
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1845-8. PubMed ID: 18030021
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial infusion chemotherapy for breast cancer].
Tokura H; Ikeda T; Kitajima M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):176-81. PubMed ID: 11865621
[TBL] [Abstract][Full Text] [Related]
6. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
Tamura K
Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
[No Abstract] [Full Text] [Related]
7. Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer.
Pacetti P; Mambrini A; Paolucci R; Sanguinetti F; Palmieri B; Della Seta R; Muttini MP; Fiorentini G; Cantore M
In Vivo; 2006; 20(6A):761-4. PubMed ID: 17203763
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
[TBL] [Abstract][Full Text] [Related]
9. [Polychemotherapy versus monotherapy in metastatic breast carcinoma].
Tanner J; Dunst J
Strahlenther Onkol; 1999 Sep; 175(9):471. PubMed ID: 10518983
[No Abstract] [Full Text] [Related]
10. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
[TBL] [Abstract][Full Text] [Related]
11. Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?
Gupta S
Nat Clin Pract Oncol; 2005 Feb; 2(2):80-1. PubMed ID: 16264879
[No Abstract] [Full Text] [Related]
12. Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.
Kerbrat P; Roché H; Bonneterre J; Veyret C; Lortholary A; Monnier A; Fumoleau P; Fargeot P; Namer M; Chollet P; Goudier MJ; Audhuy B; Simon H; Montcuquet P; Eymard JC; Walter S; Clavère P; Guastalla JP;
Br J Cancer; 2007 Jun; 96(11):1633-8. PubMed ID: 17505516
[TBL] [Abstract][Full Text] [Related]
13. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumor biological factors on response to pre-operative epirubicin and paclitaxel chemotherapy in primary breast cancer.
Warm M; Kates R; Mallmann P; Dick M; Nawroth F; Harbeck N; Paepke S; Thomas A
Anticancer Res; 2007; 27(2):1031-8. PubMed ID: 17465239
[TBL] [Abstract][Full Text] [Related]
15. A promising regimen for stage IIIB breast cancer.
Madajewicz S
Oncology (Williston Park); 1987 Sep; 1(7):17. PubMed ID: 3275346
[No Abstract] [Full Text] [Related]
16. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Yamauchi C; Mitsumori M; Sai H; Imagunbai T; Negoro Y; Sasaki Y; Hiraoka M; Shikama N; Sasaki S; Takegawa H; Inoue T; Teshima T
Jpn J Clin Oncol; 2007 Oct; 37(10):737-43. PubMed ID: 17911378
[TBL] [Abstract][Full Text] [Related]
18. Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.
Nisticò C; Bria E; Cuppone F; Fornier M; Sperduti I; Carpino A; Pace A; Cognetti F; Terzoli E
Anticancer Drugs; 2007 Jul; 18(6):687-92. PubMed ID: 17762397
[TBL] [Abstract][Full Text] [Related]
19. Side-effects of pre-operative epirubicin-paclitaxel therapy in primary breast cancer associated with tumor biology.
Warm M; Kates R; Thomas A; Fischer T; Harbeck N
Anticancer Res; 2009 Jul; 29(7):2675-80. PubMed ID: 19596945
[TBL] [Abstract][Full Text] [Related]
20. Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: what is the appropriate use of filgrastim?
Ferretti G; Lopez M; Terzoli E; Cortesi E; Antimi M; Marolla P; Giannarelli D; Cognetti F; Papaldo P
J Clin Oncol; 2006 Dec; 24(35):5618-9. PubMed ID: 17158554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
